With core technologies translated from Tsinghua University, Beijing CytoNiche Biotechnology Co., Ltd. was launched by Professor Du Yanan and its research team at the School of Medicine of Tsinghua University.  

Cytoniche focuses on creating an original 3D cell "intelligent manufacturing" platform, and provides an total solution for the large-scale customized amplification process of cells based on 3D microcarriers.

The two pharmaceutical excipient products developed by CytoNiche for cell therapy - Gelatin Microcarriers and Gelatin Microcarrier Tablets (Cell) - have received quality and safety evaluations by the National Institutes for Food and Drug Control , and have obtained 2 qualifications for pharmaceutical excipients from the National Medical Products Administration (CDE approval registration number: F20210000003, F20200000496).The latter has also obtained the Drug Master Files (DMF) qualification for pharmaceutical excipients from Food and Drug Association (FDA DMF: 35481).

The products and services of Cytoniche can be widely used in the upstream process development of gene and cell therapy, extracellular vesicles, vaccines and protein products. At the same time, it also has broad application prospects in the fields of regenerative medicine, organoids and food technology (cell cultured meat, etc.).

The company has 5000 square meters of research and development, and transformation platform, including 4000 square meters of GMP production platform, more than 1000 square meters of CDMO service platform focusing on 3D cell intelligent manufacturing and micro-tissue regenerative medicine treatment products; a new 1200 L microcarrier production line. The relevant technologies have obtained more than 100 patents and more than 30 articles about the technologies in international journals have been published. The core technology projects have obtained a number of national-level project support and applications.